February 2014

Insurers want to obey laws, but those laws are hard to understand and it is tempting to simply define coverage equality downward

But not just nursing homes. The former CMS chief wants to create efficiencies in all post-acute care settings, and looks to health plans as customers.

Can an injectable biologic really replace a delicate surgery for treatment of Dupuytren’s disease?

A bigger portion of the population is expected to have cardiac disease but live longer, and researchers argue for stopping it before it shows

Moody’s says that more people will get care, but hedges its prediction, while other experts think that the trend line will stay flat

A new precertification procedure addresses key elements in genetic testing

Departments

Legislation & Regulation

The system’s effect on the private sector has actually been underestimated. Medicare price changes often lead to amplified swings on the private side.

The Wider View

Compulsory medical insurance with a twist: Plans play a crucial role

Plan Watch

Despite last year’s fiasco at Penn State and growing concern about the effectiveness of such programs, employers are still believers

Tomorrow’s Medicine
Genome squencing has gotten so cheap that it takes oncologists’ breath away. It also raises thorny issues for health insurers.

Leave a Comment